drugset / Trial / NCT01744496

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

NCT01744496 ↗

Phase 4 Completed 68 enrolled UCB BIOSCIENCES, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This trial is being conducted to compare the impact of Rotigotine and Placebo on Chronic Pain associated with Parkinson's Disease among patients with advanced stages of the disease.

Timeline

Start
2012-11
Primary completion
2013-12
Completion
2014-01

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs Rotigotine; p = 0.172; Least Square Mean -0.76 (95% CI -1.87 to 0.34); ANCOVA NCT01744496 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotigotine Unknown — Other

Indications